Tongue cancer survivor appreciates team approach
- Diseases
- Acoustic Neuroma (14)
- Adrenal Gland Tumor (24)
- Anal Cancer (66)
- Anemia (2)
- Appendix Cancer (16)
- Bile Duct Cancer (28)
- Bladder Cancer (68)
- Brain Metastases (28)
- Brain Tumor (228)
- Breast Cancer (710)
- Breast Implant-Associated Anaplastic Large Cell Lymphoma (2)
- Cancer of Unknown Primary (4)
- Carcinoid Tumor (8)
- Cervical Cancer (154)
- Colon Cancer (164)
- Colorectal Cancer (108)
- Endocrine Tumor (4)
- Esophageal Cancer (42)
- Eye Cancer (36)
- Fallopian Tube Cancer (6)
- Germ Cell Tumor (4)
- Gestational Trophoblastic Disease (2)
- Head and Neck Cancer (4)
- Kidney Cancer (124)
- Leukemia (344)
- Liver Cancer (50)
- Lung Cancer (288)
- Lymphoma (284)
- Mesothelioma (14)
- Metastasis (30)
- Multiple Myeloma (98)
- Myelodysplastic Syndrome (60)
- Myeloproliferative Neoplasm (4)
- Neuroendocrine Tumors (16)
- Oral Cancer (98)
- Ovarian Cancer (172)
- Pancreatic Cancer (166)
- Parathyroid Disease (2)
- Penile Cancer (14)
- Pituitary Tumor (6)
- Prostate Cancer (144)
- Rectal Cancer (58)
- Renal Medullary Carcinoma (6)
- Salivary Gland Cancer (14)
- Sarcoma (234)
- Skin Cancer (294)
- Skull Base Tumors (54)
- Spinal Tumor (12)
- Stomach Cancer (60)
- Testicular Cancer (28)
- Throat Cancer (90)
- Thymoma (6)
- Thyroid Cancer (98)
- Tonsil Cancer (30)
- Uterine Cancer (78)
- Vaginal Cancer (14)
- Vulvar Cancer (18)
- Cancer Topic
- Adolescent and Young Adult Cancer Issues (20)
- Advance Care Planning (10)
- Biostatistics (2)
- Blood Donation (18)
- Bone Health (8)
- COVID-19 (362)
- Cancer Recurrence (120)
- Childhood Cancer Issues (120)
- Clinical Trials (620)
- Complementary Integrative Medicine (22)
- Cytogenetics (2)
- DNA Methylation (4)
- Diagnosis (224)
- Epigenetics (6)
- Fertility (62)
- Follow-up Guidelines (2)
- Health Disparities (14)
- Hereditary Cancer Syndromes (122)
- Immunology (18)
- Li-Fraumeni Syndrome (8)
- Mental Health (116)
- Molecular Diagnostics (8)
- Pain Management (64)
- Palliative Care (8)
- Pathology (10)
- Physical Therapy (18)
- Pregnancy (18)
- Prevention (876)
- Research (384)
- Second Opinion (74)
- Sexuality (16)
- Side Effects (596)
- Sleep Disorders (10)
- Stem Cell Transplantation Cellular Therapy (216)
- Support (404)
- Survivorship (324)
- Symptoms (182)
- Treatment (1762)
Tongue cancer survivor uses voice to support cancer research
3 minute read | Published December 15, 2016
Medically Reviewed | Last reviewed by an MD Anderson Cancer Center medical professional on December 15, 2016
When Cora “Corky” Hilliard was diagnosed with squamous cell cancer of the tongue for the second time in June 2012, she got to MD Anderson as quickly as she could. She’d had her first tongue cancer occurrence treated near her home in Austin nearly three years earlier. At the time, she’d been told that the disease would never return to its original location.
At MD Anderson, our integrated approach to cancer treatment won her admiration immediately.
“In 2009, I had to go out and find my own radiation oncologist, and I couldn’t get any direction from the doctors about who was driving the bus,” Corky says. “Then I came to MD Anderson and met with Dr. Michael Kupferman and his team, and I realized that I actually had a team. It included an oncologist, a radiologist, a surgeon, a speech therapist, a nutritionist and more, all working together. That gave me immense confidence.”
Tongue cancer treatment at MD Anderson saves speech
Corky’s confidence proved well-founded. During an Aug. 2012 robot-assisted surgery, Kupferman was able to completely remove the golf ball-sized tumor near the base of Corky’s tongue without compromising her ability to speak — a critical concern since she makes her living as a public speaker.
“I’d been told by a different doctor that if I had the surgery, only my close friends and family might eventually be able to understand me,” Corky says. “So I was facing not only the loss of my ability to communicate verbally, but also the loss of my career. MD Anderson literally gave me my voice back.”
Previous radiation exposure requires ongoing vigilance
Today, Corky considers herself lucky. None of the 30 or so lymph nodes surgically removed during the course of her treatment showed evidence of metastasis. So her second tongue cancer treatment didn’t require chemotherapy or radiation.
That was a huge relief to Corky, after the side effects she’d experienced from the high-dose radiation she’d received in 2009 as a part of her first tongue cancer treatment. “It was really painful to eat and drink then, and I had a blister on the end of my tongue for two and a half months,” she says. “I also lost my sense of taste, but eventually it came back.”
Corky is now just six months shy of the coveted five-year mark for remaining tongue cancer-free. But she must watch her body closely for signs of secondary cancers caused by her previous radiation exposure.
“I just had a basal cell cancer removed from my right eyelid,” Corky says. “When I asked Dr. Richard Allen if it could be related to all the radiation I received back in 2009, he said, ‘No doubt.’ So I pay careful attention.”
Why Corky gives back to MD Anderson
Corky also finds great satisfaction in using her voice to give back to the place that helped her to keep it.
She began donating annually to MD Anderson in 2012, and she encourages others to do the same.
“I earmark my donations for Dr. Kupferman’s research,” Corky says. “I know it’s a little self-serving since he’s studying my kind of cancer, but I wanted to feel like I was contributing in some way. State support for government institutions like MD Anderson has been steadily diminishing, and Dr. K. saved my life. This lets me feel like I’m paying my own way and doing my part.”
Make a gift to MD Anderson to support cancer research that benefits patients like Corky.
Related Cancerwise Stories

MD Anderson literally gave me my voice back.
Corky Hilliard
Survivor
